[{"ID":"12720_27_NCT03296930","TOPIC_YEAR":2021,"RESPONSE":"beskreve","PROBA":0.2245076963},{"ID":"30672_65_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"\u05c1A","PROBA":0.457198938},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"Since the patient has chronic HCV infection, which is the primary inclusion criterion for the clinical trial, the patient is eligible for the trial. Therefore, the answer is (A) eligible.","PROBA":0.8844301883},{"ID":"17032_36_NCT01491828","TOPIC_YEAR":2021,"RESPONSE":"$}}%eria%}>A) eligible<\/textarea>\n\nThe patient is eligible for the clinical trial based on the inclusion criteria. The patient is a female who is at least 18 years old, has a BMI of 41.54, and has complaints of sleep apnea and PCO. These conditions are all included in the inclusion criteria for the clinical trial. Additionally, the patient does not have any excluded conditions such as known hyposensitivity or hypersensitivity to vibrations on neck, neurological disorder, psychiatric disorders currently not under control, insomnia, or pregnancy. Therefore, the patient is eligible for the clinical trial.","PROBA":0.8686725415},{"ID":"7100_15_NCT04821219","TOPIC_YEAR":2021,"RESPONSE":"textt\n\nB: excluded","PROBA":0.6483303861},{"ID":"8090_17_NCT04210791","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%]  A: eligible","PROBA":0.7324717201},{"ID":"7091_15_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"\u0450A: eligible","PROBA":0.804877447},{"ID":"10176_15_NCT02081625","TOPIC_YEAR":2022,"RESPONSE":"d\u00e1tummal: eligible","PROBA":0.6614480975},{"ID":"12547_27_NCT01750515","TOPIC_YEAR":2021,"RESPONSE":"isserAnswer\n\nB: excluded","PROBA":0.6816455482},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"sl\u00e4ktet B: excluded","PROBA":0.6774743361},{"ID":"12485_27_NCT01292161","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nbased on the patient note, the patient is eligible for the clinical trial, therefore, the answer is (A) eligible. The patient has chronic HCV infection, which is the primary inclusion criterion for the clinical trial. Additionally, the patient is currently receiving IFN and RBV combination therapy, which is consistent with the trial's inclusion criteria. There are no exclusion criteria listed in the patient note that would disqualify the patient from participating in the trial.","PROBA":0.8902424247},{"ID":"7792_17_NCT00961467","TOPIC_YEAR":2021,"RESPONSE":"\u042c: excluded","PROBA":0.7188306211},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"","PROBA":0.0134115526},{"ID":"7690_17_NCT00153933","TOPIC_YEAR":2021,"RESPONSE":"\u0450A: eligible","PROBA":0.806014845},{"ID":"14123_30_NCT02758977","TOPIC_YEAR":2021,"RESPONSE":"oppurtunity to answer\n\nA) eligible","PROBA":0.6786626264},{"ID":"11608_17_NCT01695369","TOPIC_YEAR":2022,"RESPONSE":"\u01ebA","PROBA":0.5131702529},{"ID":"30849_65_NCT03362762","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nbased on the patient's note, the patient is eligible for the clinical trial because none of the exclusion criteria is met. Therefore, the best answer is A: eligible.","PROBA":0.8287409565},{"ID":"5559_12_NCT04731493","TOPIC_YEAR":2021,"RESPONSE":"sl\u00e4ktet","PROBA":0.0423955079},{"ID":"30801_65_NCT02782195","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nbased on the patient note, the patient is eligible for the clinical trial. The patient has type 1 diabetes, which is an inclusion criteria, and does not have any of the exclusion criteria listed, such as other physical or psychological diseases, current treatment with drugs known to interfere with glucose metabolism, or a history of severe hypoglycemic unawareness. Additionally, the patient's age and gender are within the inclusion criteria range of 16-24 years and male, respectively. Therefore, the correct answer is (A) eligible.","PROBA":0.8906541096},{"ID":"6986_15_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"$}}%>","PROBA":0.4010974243},{"ID":"7703_17_NCT00256776","TOPIC_YEAR":2021,"RESPONSE":"MDb: eligible","PROBA":0.8038234253},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"ing\u00e5r","PROBA":0.2649160661},{"ID":"7701_17_NCT00240162","TOPIC_YEAR":2021,"RESPONSE":"# Answer: C # Not relevant for clinical trial. The patient's condition is not relevant to the clinical trial, as the trial is focused on a specific type of multiple myeloma and the patient has a different condition (amyloidosis).","PROBA":0.7686320453},{"ID":"25463_36_NCT03600324","TOPIC_YEAR":2022,"RESPONSE":"sl\u00e4ktet","PROBA":0.1403975273},{"ID":"14162_30_NCT03296878","TOPIC_YEAR":2021,"RESPONSE":"trightarrow A: eligible","PROBA":0.7563356725},{"ID":"6964_15_NCT03578445","TOPIC_YEAR":2021,"RESPONSE":"(A) eligible (B) excluded (C) not relevant for clinical trial","PROBA":0.9260465489},{"ID":"10316_15_NCT03433807","TOPIC_YEAR":2022,"RESPONSE":"$}}%A%>","PROBA":0.589150086},{"ID":"16862_36_NCT00105066","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B Based on the patient's information, she is not eligible for the clinical trial.{%E2%80%8B the clinical trial excludes patients with a history of diabetes treated with medication, which the patient has. Additionally, the patient's BMI (41.54) is outside the range of the trial's inclusion criteria (BMI 30-40).","PROBA":0.8034375264},{"ID":"27576_40_NCT00970658","TOPIC_YEAR":2022,"RESPONSE":"$}}%3B)%20B%20Excluded%7C%20not%20relevant%20for%20clinical%20trial)%20or%20a%20more%20specific%20answer%20based%20on%20the%20patient's%20condition%20and%20the%20inclusion%20and%20exclusion%20criteria%20of%20the%20study.","PROBA":0.8479231257},{"ID":"10221_15_NCT02398786","TOPIC_YEAR":2022,"RESPONSE":"$}}%efn%efn\n\nA: eligible","PROBA":0.5483319876},{"ID":"12509_27_NCT01498068","TOPIC_YEAR":2021,"RESPONSE":"d\u00e1tummal\n\nB","PROBA":0.3982962141},{"ID":"21420_30_NCT04397484","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.5913417102},{"ID":"12359_27_NCT00164073","TOPIC_YEAR":2021,"RESPONSE":"$}}%5B%20A%3Am%20%3BEL%5D%20)\">A) eligible","PROBA":0.5566106602},{"ID":"7078_15_NCT04604730","TOPIC_YEAR":2021,"RESPONSE":"\u043a\u0440\u0430\u0457\u043d","PROBA":0.0884454972},{"ID":"17158_36_NCT02556749","TOPIC_YEAR":2021,"RESPONSE":"texttospeech_sdk.tts.models.response.A","PROBA":0.502069622},{"ID":"25316_36_NCT02467244","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB) excluded","PROBA":0.6661241134},{"ID":"11768_17_NCT02793232","TOPIC_YEAR":2022,"RESPONSE":"$}}%C: not relevant for clinical trial. The patient is not eligible for the clinical trial because they have a slowly worsening vision, which is not a condition that is being studied in the clinical trial. The clinical trial is focused on the safety, tolerability, and blood concentrations of PF-06751979 in healthy volunteers and healthy elderly volunteers, and it does not include conditions related to vision. Therefore, the patient's condition would not meet the inclusion criteria for the clinical trial.","PROBA":0.8831035701},{"ID":"14125_30_NCT02789163","TOPIC_YEAR":2021,"RESPONSE":"ultimo eligible","PROBA":0.5507165899},{"ID":"17322_36_NCT03802734","TOPIC_YEAR":2021,"RESPONSE":"ppo3811","PROBA":0.0698529915},{"ID":"5533_12_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"beskrebetompson\n\nBased on the patient's note, the patient is eligible for the clinical trial. The patient has severe mitral regurgitation due to posterior leaflet prolapse, which aligns with the inclusion criteria of the clinical trial. Additionally, the patient has a history of gestational diabetes mellitus, hypertension, and obesity, which are not exclusion criteria for the trial. Therefore, option A (eligible) is the best response.","PROBA":0.8882274786},{"ID":"10050_15_NCT00830583","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB based on the following reasons:\n\n1. The patient has a diagnosis of DMD, which is an etiologic muscular disease that is not included in the exclusion criteria.\n2. The patient does not have a confirmed diagnosis of Pompe disease, which is the primary inclusion criterion of the clinical trial.\n3. The patient's background does not have a X-link or a dominant transmission, which is an exclusion criterion.\n4. The patient has not had confirmation of Pompe disease by biochemical analysis and\/or molecular biology, which is an exclusion criterion.\n5. The patient has not had GAA enzymatic activity performed, which is an exclusion criterion.\n\nTherefore, the patient is excluded from the clinical trial.","PROBA":0.929847052},{"ID":"5530_12_NCT04343313","TOPIC_YEAR":2021,"RESPONSE":"  A: eligible\n   B: excluded\n   C: not relevant for clinical trial","PROBA":0.9109958366},{"ID":"10317_15_NCT03439670","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.7285093423},{"ID":"30427_65_NCT00283218","TOPIC_YEAR":2021,"RESPONSE":"$}}%3B)","PROBA":0.2789530186},{"ID":"25356_36_NCT02733549","TOPIC_YEAR":2022,"RESPONSE":"beskreber","PROBA":0.1657207434},{"ID":"21413_30_NCT04381624","TOPIC_YEAR":2022,"RESPONSE":"ing\u00e5r\n\nThe patient is eligible for the clinical trial because none of the exclusion criteria are present in the patient's record. The patient does not have any of the symptoms and signs listed in exclusion criteria 1, and there is no evidence of psychiatric or neurological diseases (exclusion criteria 2). The patient does not have any neuromuscular or cardiac disorders, stroke, generalized rheumatology, diabetes mellitus II, morbid obesity (exclusion criteria 3), medical contraindication of physical exercise (exclusion criteria 4), joint infiltration or lower limb surgery in the previous 6 months (exclusion criteria 5), surgery is planned for the next 6 months (exclusion criteria 6), use of oral steroids or opioids in the last 4 weeks (exclusion criteria 7), or conditions that affect the lower limb and\/or limit its functional capacity (exclusion criteria 8). The patient is also not participating in exercise programs in the last nine months (exclusion criteria 9) and is able to follow instructions (exclusion criteria 10). Based on the patient's record, the patient is eligible for the clinical trial.","PROBA":0.9199049907},{"ID":"12714_27_NCT03241823","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nbased on the patient's note, the patient is (B) excluded from the clinical trial because they have liver cirrhosis, which is exclusion criterion number 1.","PROBA":0.8541848863},{"ID":"6561_15_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"_____________________________\n\nPlease select one of the options in the bracket:\n(A) eligible, (B) excluded, (C) not relevant for clinical trial","PROBA":0.8155767017},{"ID":"33403_71_NCT00297154","TOPIC_YEAR":2021,"RESPONSE":"\u01ebA: eligible","PROBA":0.795031431},{"ID":"21305_30_NCT03736109","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\n based on the patient's note and the inclusion and exclusion criteria of the clinical trial, the patient is eligible for the clinical trial, so the answer is (A) eligible. The patient meets the inclusion criteria of the clinical trial, which is osteoarthritis, and does not have any of the exclusion criteria, such as being pregnant or breastfeeding, having a prosthesis replaced in the past 12 months, or obesity. Additionally, the patient's symptoms of pain and limited activity are consistent with the condition being studied in the clinical trial.","PROBA":0.8994184263}]
